Do No Harm

Opioid Heroin in the News

Opioid Heroin: Do no harm
The treatment itself also carried unnecessary risks as the accelerated withdrawal from opioids (usually heroin) required the patient to undergo general anaesthesia for 24 hours. Proponents of this treatment mistakenly argued that it would restore the
Read more on Cosmos

Opioid Heroin: Titan Pharmaceuticals Provides Additional Positive Results in Confirmatory
The World Health Organization estimates that between 4.6 and 5.2 million individuals in the US and Europe use illicit opioids such as heroin, and more than 2.0 million individuals in the US alone are addicted to prescription opioid medications.
Read more on MarketWatch (press release)

Opioid Heroin: SALOME video – Part 1

The Study to Assess Long-term Opioid Maintenance Effectiveness (SALOME) is a clinical trial that will test whether diacetylmorphine, the active ingredient of heroin, is as good as hydromorphone (Dilaudid®), a licensed medication, in benefiting people suffering from chronic opioid addiction who are not benefiting sufficiently from other treatments. This study will also test if those effectively treated with these two injectable medications can be successfully switched and retained to the oral formulations of the medications.

More Opioid Heroin Information…